Glycomics/Glycobiology Market - Global Forecast 2026-2032

The Glycomics/Glycobiology Market is rapidly evolving, driven by technological advances and increasing demand for high-quality analytics within the global life sciences sector. Forward-thinking leaders must understand the operational shifts and strategic opportunities that define this market as it shapes the future of translational research, drug development, and diagnostics.

Market Snapshot

The Glycomics/Glycobiology Market grew from USD 2.06 billion in 2025 to USD 2.32 billion in 2026. It is expected to continue growing at a CAGR of 12.66%, reaching USD 4.76 billion by 2032. Market expansion is fuelled by next-generation analytical capabilities, cross-disciplinary collaborations, and accelerated adoption across the research and biopharma spectrum. As glycan analysis integrates into core life sciences workflows, demand for advanced instrumentation, reagents, and specialized services is reshaping supplier strategies and competitive positioning.

Scope & Segmentation

Product Types: Enzymes such as glycosidases, glycosyltransferases, and sulfatases unlock selective modification and probing of glycan structures. Instruments—including arrays, chromatography, mass spectrometry, and HPLC systems—are evolving toward automated, end-to-end solutions. Kits like glycan and glycoprotein labeling or purification simplify high-complexity methods. Reagents and chemicals underpin repeatable, high-fidelity analysis.
Applications: Diagnostics (including cancer, genetic, and infectious disease testing), therapeutics (drug delivery, development, and discovery), and bioprocess control leveraging glycoengineering. Glycan-based biomarkers and molecular signatures increasingly inform clinical research and targeted therapies.
End Users: Academic research institutes lead innovation and methodology. Contract research organizations scale analytics and reporting. Pharmaceutical and biotech companies integrate glycoanalytics into their R&D pipelines and quality-control frameworks.
Regions: Americas benefit from established biopharma and service networks. EMEA features strong regulatory compliance, harmonized documentation, and public-private initiatives. Asia-Pacific accelerates adoption with expanding infrastructure and cost-competitive manufacturing.
Technologies: Leading advances include high-sensitivity mass spectrometry, targeted fragmentation, microarrays, automated sample prep, and tailored enzyme engineering. These foster increased throughput, accuracy, and inclusivity in multi-omic workflows.

Key Takeaways

Next-generation analytical advances and cross-disciplinary efforts position glycomics as a pillar in modern life sciences research, with expanding applications across oncology, immunology, and rare disease investigation.
Growing regulatory scrutiny around glycosylation in biologics heightens quality expectations, driving the need for validated workflows and reproducible standards.
Strategic collaborations among instrument makers, reagent suppliers, and contract research organizations create integrated solutions that drive faster, more reliable project delivery.
Segmentation reveals value accrues to bundled platforms, certified reagents, and flexible partnership models that bridge discovery research to regulated manufacturing environments.
Regional adoption rates and supply chain strategies are influenced by local infrastructure, trade policies, and government investment, creating unique opportunities for both local and global suppliers.
Companies that invest in user training, application support, and data interoperability achieve accelerated adoption among mainstream biopharma and diagnostic developers.

Tariff Impact

Recent and upcoming tariff shifts directly affect procurement strategies, supply chain resilience, and U.S. manufacturing for glycomics. Organizations are diversifying suppliers, expanding domestic assembly, and strengthening regional distribution to reduce exposure to cost fluctuations and trade disruptions. This environment increases reliance on flexible inventory management and collaborative service providers.

Methodology & Data Sources

This report draws on in-depth interviews with industry, academic, and procurement leaders, supported by structured questionnaires and cross-analysis of scientific literature, technical documents, and regulatory filings. Data integrity was ensured by triangulating sources, validating discrepant data, and documenting search and assessment protocols throughout the research process.

Why This Report Matters

Provides a strategic market lens to benchmark your investment, partnership, and regional expansion plans in the glycomics ecosystem.
Delivers actionable segmentation, operational strategies, and supplier insights to empower procurement and R&D decision-making.
Equips commercial leaders and technical teams with the latest evidence-driven trends in analytics, quality, and supply chain adaptation.

Conclusion

The glycomics market is transitioning into a cornerstone for modern life sciences. Leaders aligning technology, talent, and supply strategies are positioned to drive lasting value and resilience across research and product development.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Glycomics/Glycobiology Market, by Product Type

8.1. Enzymes
8.1.1. Glycosidases & Neuramidases
8.1.2. Glycosyltransferases & Sialytransferases
8.1.3. Protein Sulfotransferases & Sulfatases
8.2. Instruments
8.2.1. Arrays
8.2.2. Chromatography Instruments
8.2.3. Electrophoresis Instruments
8.2.4. HPLC Columns
8.2.5. Mass Spectrometry Instruments
8.3. Kits
8.3.1. Glycan Labeling Kits
8.3.2. Glycan Purification Kits
8.3.3. Glycoprotein Labeling Kits
8.4. Reagents & Chemicals

9. Glycomics/Glycobiology Market, by Applications

9.1. Diagnostics
9.1.1. Cancer Detection
9.1.2. Genetic Disorders
9.1.3. Infectious Diseases
9.2. Therapeutics
9.2.1. Drug Delivery Systems
9.2.2. Drug Development
9.2.3. Drug Discovery

10. Glycomics/Glycobiology Market, by End-User

10.1. Academic Research Institutes
10.2. Contract Research Organizations
10.3. Pharmaceutical & Biotechnology Companies

11. Glycomics/Glycobiology Market, by Region

11.1. Americas
11.1.1. North America
11.1.2. Latin America
11.2. Europe, Middle East & Africa
11.2.1. Europe
11.2.2. Middle East
11.2.3. Africa
11.3. Asia-Pacific

12. Glycomics/Glycobiology Market, by Group

12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO

13. Glycomics/Glycobiology Market, by Country

13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea

14. United States Glycomics/Glycobiology Market
15. China Glycomics/Glycobiology Market

16. Competitive Landscape

16.1. Market Concentration Analysis, 2025
16.1.1. Concentration Ratio (CR)
16.1.2. Herfindahl Hirschman Index (HHI)
16.2. Recent Developments & Impact Analysis, 2025
16.3. Product Portfolio Analysis, 2025
16.4. Benchmarking Analysis, 2025
16.5. Agilent Technologies, Inc.
16.6. AMSBIO
16.7. Asparia Glycomics
16.8. Bio-Techne Corporation
16.9. Bruker Corporation
16.10. Chemily Glycoscience
16.11. Creative Diagnostics
16.12. FUJIFILM Wako Pure Chemical Corporation
16.13. Genos Glyco
16.14. Glycan Therapeutics
16.15. GlycoDiag
16.16. glyXera GmbH
16.17. Lectenz Bio, Inc.
16.18. Ludger Ltd
16.19. Megazyme Ltd. by Neogen Corporation
16.20. Merck KGaA
16.21. New England Biolabs, Inc.
16.22. QIAGEN N.V.
16.23. RayBiotech, Inc.
16.24. Revvity, Inc.
16.25. SCIEX by Danaher Corporation
16.26. Shimadzu Corporation
16.27. Sumitomo Bakelite Co., Ltd.
16.28. Takara Bio Inc.
16.29. Thermo Fisher Scientific Inc.
16.30. Tokyo Chemical Industry Co., Ltd.
16.31. Vector Laboratories, Inc.
16.32. Waters Corporation
16.33. Z Biotech, LLC
16.34. Zacharon Pharmaceuticals, Inc.

List of Figures

FIGURE 1. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 11. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSIDASES & NEURAMIDASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSIDASES & NEURAMIDASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSIDASES & NEURAMIDASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSYLTRANSFERASES & SIALYTRANSFERASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSYLTRANSFERASES & SIALYTRANSFERASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOSYLTRANSFERASES & SIALYTRANSFERASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PROTEIN SULFOTRANSFERASES & SULFATASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PROTEIN SULFOTRANSFERASES & SULFATASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PROTEIN SULFOTRANSFERASES & SULFATASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ELECTROPHORESIS INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ELECTROPHORESIS INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ELECTROPHORESIS INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY HPLC COLUMNS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY HPLC COLUMNS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY HPLC COLUMNS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY MASS SPECTROMETRY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN LABELING KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN LABELING KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN LABELING KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN PURIFICATION KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN PURIFICATION KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCAN PURIFICATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOPROTEIN LABELING KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOPROTEIN LABELING KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GLYCOPROTEIN LABELING KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REAGENTS & CHEMICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REAGENTS & CHEMICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REAGENTS & CHEMICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CANCER DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CANCER DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CANCER DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 128. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 129. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 130. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 131. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 132. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 143. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 146. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 147. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 148. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 149. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 150. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 151. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. ASEAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 165. ASEAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 166. ASEAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 167. ASEAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 168. ASEAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 169. ASEAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 170. ASEAN GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 171. GCC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GCC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. GCC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 174. GCC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 175. GCC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 176. GCC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 177. GCC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 178. GCC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 179. GCC GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 189. BRICS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. BRICS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. BRICS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 192. BRICS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 193. BRICS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 194. BRICS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 195. BRICS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 196. BRICS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 197. BRICS GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 198. G7 GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. G7 GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. G7 GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 201. G7 GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 202. G7 GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 203. G7 GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 204. G7 GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 205. G7 GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 206. G7 GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 207. NATO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. NATO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 209. NATO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 210. NATO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 211. NATO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 212. NATO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 213. NATO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 214. NATO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 215. NATO GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 226. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 229. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 230. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
TABLE 231. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY APPLICATIONS, 2018-2032 (USD MILLION)
TABLE 232. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 233. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 234. CHINA GLYCOMICS/GLYCOBIOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Glycomics/Glycobiology market report include:

Agilent Technologies, Inc.
AMSBIO
Asparia Glycomics
Bio-Techne Corporation
Bruker Corporation
Chemily Glycoscience
Creative Diagnostics
FUJIFILM Wako Pure Chemical Corporation
Genos Glyco
Glycan Therapeutics
GlycoDiag
glyXera GmbH
Lectenz Bio, Inc.
Ludger Ltd
Megazyme Ltd. by Neogen Corporation
Merck KGaA
New England Biolabs, Inc.
QIAGEN N.V.
RayBiotech, Inc.
Revvity, Inc.
SCIEX by Danaher Corporation
Shimadzu Corporation
Sumitomo Bakelite Co., Ltd.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
Tokyo Chemical Industry Co., Ltd.
Vector Laboratories, Inc.
Waters Corporation
Z Biotech, LLC
Zacharon Pharmaceuticals, Inc.

Table Information

Report Attribute	Details
No. of Pages	194
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.32 Billion
Forecasted Market Value ( USD ) by 2032	$ 4.76 Billion
Compound Annual Growth Rate	12.6%
Regions Covered	Global
No. of Companies Mentioned	31

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3471EUR$3,939USD£3,022GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3745EUR$4,249USD£3,259GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5075EUR$5,759USD£4,418GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6142EUR$6,969USD£5,346GBP

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Glycomics Or Glycobiology Market Report 2025

Glycomics / Glycobiology - Global Strategic Business Report

Glycobiology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Glycomics Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033

Glycomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F